Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods

Details for Australian Patent Application No. 2003298912 (hide)

Owner University of Massachusetts Advanced Bioscience Laboratories, Inc.

Inventors Lu, Shan; Keen, Tim; Pal, Ranajit; Kalyanaraman, V. S.; Wang, Shixia; Nair, Balachandran C.; Whitney, Stephen Charles; Markham, Phillip

Agent Davies Collison Cave

Pub. Number AU-B-2003298912

PCT Number PCT/US2003/0386

PCT Pub. Number WO2004/050856

Priority 60/503,907 19.09.03 US; 60/430,732 03.12.02 US

Filing date 3 December 2003

Wipo publication date 23 June 2004

Acceptance publication date 2 June 2011

International Classifications

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/503,907 19.09.03 US; 60/430,732 03.12.02 US

29 July 2004 Application Open to Public Inspection

  Published as AU-B-2003298912

2 June 2011 Application Accepted

  Published as AU-B-2003298912

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003298913-TREATMENT OF INFLAMMATORY DISORDERS WITH 2,3-BENZODIAZEPINES

2003298911-CYCLOSPORINS FOR THE TREATMENT OF AUTOIMMUNE DISEASES